Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Could This $6.5 Billion Acquisition Help Turn Biogen's Business Around?
Could This $6.5 Billion Acquisition Help Turn Biogen's Business Around?
Could This $6.5 Billion Acquisition Help Turn Biogen's Business Around?
Submitted by
admin
on August 10, 2023 - 9:57am
Source:
Motley Fool
News Tags:
Biogen
Reata Pharmaceuticals
M&A
Skyclarys
Headline:
Could This $6.5 Billion Acquisition Help Turn Biogen's Business Around?
snippet:
Biogen recently announced plans to acquire Reata Pharmaceuticals.
The deal would give Biogen a potential blockbuster drug in Skyclarys.
Do Not Allow Advertisers to Use My Personal information
